A description of the invention will be available after the patent application is published. Nencki Institute is the sole applicant. For more information contact Technology Transfer Office.
A description of the invention will be available after the patent application is published. Nencki Institute is the co-applicant with University of Warsaw and National Medicines Institutes. University of Warsaw is the leader in patent protection and commercialization-related activities. For more information contact Technology Transfer Office.
A description of the invention will be available after the patent application is published. Nencki Institute is the co-applicant with University of Warsaw. University of Warsaw is the leader in patent protection and commercialization-related activities. For more information contact Technology Transfer Office.
A description of the invention will be available after the patent application is published. Nencki Institute is the sole applicant. For more information contact Technology Transfer Office.
Isolated peptides, compositions and methods of use for treating tumors infiltrated with macrophages, such as glioblastoma. For more information contact Technology Transfer Office.
A panel of blood RNA markers for the prediction of epilepsy, in particular drug resistant epilepsy, in girls aged up to 24 months with tuberous sclerosis. Nencki Institute is the co-applicant with Medical University of Warsaw, International Institute of Molecular and Cell Biology in Warsaw, and Children’s Memorial Health Institute in Warsaw. Medical University of Warsaw is the leader in patent protection and commercialization-related activities. For more…
A panel of blood RNA markers for the prediction of the occurrence of epilepsy recurrence following drug withdrawal in patients with tuberous sclerosis. Nencki Institute is the co-applicant with Medical University of Warsaw, International Institute of Molecular and Cell Biology in Warsaw, and Children’s Memorial Health Institute in Warsaw. Medical University of Warsaw is the leader in patent protection and commercialization-related activities. For more…
Description of the invention will be available after the patent application is published.
Description of the invention will be available after the patent application is published.